Highly reproducible bactericidal activity test results by using a modified national committee for clinical laboratory standards broth macrodilution technique

被引:42
作者
Hacek, DM
Dressel, DC
Peterson, LR
机构
[1] NW Mem Hosp, Dept Pathol, Clin Microbiol Div, Chicago, IL 60611 USA
[2] NW Mem Hosp, Dept Med, Div Infect Dis, Chicago, IL 60611 USA
[3] Northwestern Univ, Sch Med, Chicago, IL 60611 USA
关键词
D O I
10.1128/JCM.37.6.1881-1884.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bactericidal testing historically has exhibited variable reproducibility, even when prior standardized methods were employed. Several modifications to the National Committee for Clinical Laboratory Standards (NCCLS) broth macrodilution method are proposed to improve reproducibility, Recommended changes from the approved NCCLS guidelines (M21-A and M26-A) include omitting serum supplementation of Mueller-Hinton broth, incubating tubes at 35 degrees C for 24 h with no agitation until they are sampled, running all tests in duplicate with six dilutions instead of nine, reincubating the test for an additional 24 h to resolve discrepant bactericidal activity test results, using a single 0.1-ml sample from each clear tube for subculture, and adopting an alternate method for calculating endpoint determination. In order to test these recommendations in a clinical laboratory setting, we used the modified methodology on 224 separate tests for bactericidal activity. There were 102 serum bactericidal titer (SBT) and 122 minimum bactericidal concentration (MBC) assays performed. By defining reproducibility as agreement between duplicate tests +/- 1 dilution, we found 207 of 224 tests (92%) were reproducible at the 24-h subculture point (94% for the SET assay and 91% for the MBC assay), When the 17 assays with discrepant results were incubated an additional 24 h for a second subculture, only 1 of 224 tests (0.4%) remained discrepant. The method used is practical for a clinical laboratory that chooses to perform bactericidal activity testing and assures a high level of reproducibility between duplicate assays. The total cost of a test was approximately $25.00.
引用
收藏
页码:1881 / 1884
页数:4
相关论文
共 26 条
[1]  
Anhalt J.P., 1980, MANUAL CLIN MICROBIO, P478
[2]   The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s [J].
Armstrong, D ;
Neu, H ;
Peterson, LR ;
Tomasz, A .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (01) :1-4
[3]   CIPROFLOXACIN, AZLOCILLIN, CEFTIZOXIME AND AMIKACIN ALONE AND IN COMBINATION AGAINST GRAM-NEGATIVE BACILLI IN AN INFECTED CHAMBER MODEL [J].
BAMBERGER, DM ;
PETERSON, LR ;
GERDING, DN ;
MOODY, JA ;
FASCHING, CE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (01) :51-63
[4]  
CHEN RF, 1967, J BIOL CHEM, V242, P173
[5]   ANTIMICROBIAL SUSCEPTIBILITY TESTS AND THEIR ROLE IN THERAPEUTIC DRUG-MONITORING [J].
DEGIROLAMI, PC ;
ELIOPOULOS, G .
CLINICS IN LABORATORY MEDICINE, 1987, 7 (03) :499-512
[6]  
FASCHING CE, 1990, J LAB CLIN MED, V116, P697
[7]   MEZLOCILLIN, CEFTIZOXIME, AND AMIKACIN ALONE AND IN COMBINATION AGAINST 6 ENTEROBACTERIACEAE IN A NEUTROPENIC SITE IN RABBITS [J].
GERDING, DN ;
PETERSON, LR ;
MOODY, JA ;
FASCHING, CE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 :207-219
[8]   OCCURRENCE AND REPRODUCIBILITY OF THE SKIP PHENOMENON IN BACTERICIDAL TESTING OF STAPHYLOCOCCUS-AUREUS [J].
GRESSERBURNS, ME ;
SHANHOLTZER, CJ ;
PETERSON, LR ;
GERDING, DN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 6 (04) :335-342
[9]   ANTIMICROBIAL SUSCEPTIBILITY TESTING - A CRITICAL-EVALUATION [J].
ISENBERG, HD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 :73-86
[10]   ENERGY AND EXERGY ANALYSIS OF A CHEMICAL PROCESS SYSTEM WITH DISTRIBUTED PARAMETERS BASED ON THE ENTHALPY DIRECTION FACTOR DIAGRAM [J].
ISHIDA, M ;
KAWAMURA, K .
INDUSTRIAL & ENGINEERING CHEMISTRY PROCESS DESIGN AND DEVELOPMENT, 1982, 21 (04) :690-695